Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

MK-677 and Phenylpiracetam Interaction: Monitor | Peptide Database

Can you take MK-677 with Phenylpiracetam? Monitor interaction (51% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

MK-677

Ghrelin Receptor Agonist | Oral Growth Hormone Secretagogue

Selectively binds GHS-R1a receptors in hypothalamus and pituitary, triggering pulsatile growth hormone release while maintaining natural circadian patterns..

Phenylpiracetam

Racetam Nootropic | Cognitive & Physical Performance

Phenylpiracetam modulates multiple neurotransmitter systems, which accounts for its broad spectrum of cognitive and physical effects. Like other racetams, it acts as a positive allosteric modulator of AMPA receptors, enhancing glutamatergic transmission and facilitating long-term potentiation in hippocampal circuits critical for memory formation.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take MK-677 with Phenylpiracetam?

Yes, but with caution. Both MK-677 and Phenylpiracetam can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). Regular monitoring is advised.

Is MK-677 and Phenylpiracetam safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: blood pressure raising, teratogenic. Monitor accordingly.

What are the interactions between MK-677 and Phenylpiracetam?

Both MK-677 and Phenylpiracetam can raise blood pressure. Monitor BP regularly and consider adding cardiovascular support (cardarine, telmisartan, or similar). This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time MK-677 and Phenylpiracetam?

MK-677 has a half-life of ~24 hours and Phenylpiracetam has a half-life of ~3-5 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question